BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31492033)

  • 1. The Impact of
    Picharski GL; Andrade DP; Fabro ALMR; Lenzi L; Tonin FS; Ribeiro RC; Figueiredo BC
    Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31492033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inferior prognostic outcome in acute promyelocytic leukemia with alterations of FLT3 gene.
    Yoo SJ; Park CJ; Jang S; Seo EJ; Lee KH; Chi HS
    Leuk Lymphoma; 2006 Sep; 47(9):1788-93. PubMed ID: 17064989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Effects of the FLT3-ITD Mutation on Chemotherapy Response and Prognosis of Acute Promyelocytic Leukemia.
    Song YH; Peng P; Qiao C; Li JY; Long QQ; Lu H
    Cancer Manag Res; 2021; 13():2371-2378. PubMed ID: 33737834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients.
    Chillón MC; Santamaría C; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Marín L; Caballero MD; Vidriales MB; Ramos F; Bernal T; Díaz-Mediavilla J; García de Coca A; Peñarrubia MJ; Queizán JA; Giraldo P; San Miguel JF; González M
    Haematologica; 2010 May; 95(5):745-51. PubMed ID: 20133893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.
    Callens C; Chevret S; Cayuela JM; Cassinat B; Raffoux E; de Botton S; Thomas X; Guerci A; Fegueux N; Pigneux A; Stoppa AM; Lamy T; Rigal-Huguet F; Vekhoff A; Meyer-Monard S; Ferrand A; Sanz M; Chomienne C; Fenaux P; Dombret H;
    Leukemia; 2005 Jul; 19(7):1153-60. PubMed ID: 15889156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of FLT3 ITD and D835 mutations in AML patients.
    Sheikhha MH; Awan A; Tobal K; Liu Yin JA
    Hematol J; 2003; 4(1):41-6. PubMed ID: 12692519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia.
    Gale RE; Hills R; Pizzey AR; Kottaridis PD; Swirsky D; Gilkes AF; Nugent E; Mills KI; Wheatley K; Solomon E; Burnett AK; Linch DC; Grimwade D;
    Blood; 2005 Dec; 106(12):3768-76. PubMed ID: 16105978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence and clinical significance of FLT3 mutations in acute promyelocytic leukemia].
    Xue MX; Qiu HY; Feng YF; Zhu ZL; Chang WR; Liang JY; Chen SN; Cen JN; Xue YQ; Liu YJ; Sun AN; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):757-61. PubMed ID: 19176014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol.
    Noguera NI; Breccia M; Divona M; Diverio D; Costa V; De Santis S; Avvisati G; Pinazzi MB; Petti MC; Mandelli F; Lo Coco F
    Leukemia; 2002 Nov; 16(11):2185-9. PubMed ID: 12399960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy.
    Barragán E; Montesinos P; Camos M; González M; Calasanz MJ; Román-Gómez J; Gómez-Casares MT; Ayala R; López J; Fuster Ó; Colomer D; Chillón C; Larrayoz MJ; Sánchez-Godoy P; González-Campos J; Manso F; Amador ML; Vellenga E; Lowenberg B; Sanz MA; ;
    Haematologica; 2011 Oct; 96(10):1470-7. PubMed ID: 21685470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [FLT3-ITD Mutation in Newly Diagnosed Patients with Acute Promyelocytic Leukemia].
    Gong BF; Wang Y; Lin D; Wei H; Li W; Zhou CL; Liu BC; Liu KQ; Zhang GJ; Liu YT; Li Y; Wei SN; Gong XY; Zhao XL; Qiu SW; Gu RX; Mi YC; Wang JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1615-1621. PubMed ID: 28024465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.
    Lucena-Araujo AR; Kim HT; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Chauffaille Mde L; Chiattone CS; Lima AS; Ruiz-Argüelles G; Undurraga MS; Martinez L; Kwaan HC; Gallagher R; Niemeyer CM; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
    Ann Hematol; 2014 Dec; 93(12):2001-10. PubMed ID: 24981688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: a systematic review.
    Beitinjaneh A; Jang S; Roukoz H; Majhail NS
    Leuk Res; 2010 Jul; 34(7):831-6. PubMed ID: 20096459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLT3/ITD associated with an immature immunophenotype in PML-RARα leukemia.
    Takenokuchi M; Kawano S; Nakamachi Y; Sakota Y; Syampurnawati M; Saigo K; Tatsumi E; Kumagai S
    Hematol Rep; 2012 Nov; 4(4):e22. PubMed ID: 23355940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [FLT3 gene mutation and its prognostic implication in patients with acute leukemia.].
    Sino-US Shanghai Leukemia Cooperative Group
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jan; 31(1):1-5. PubMed ID: 20302766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia.
    Colovic N; Tosic N; Aveic S; Djuric M; Milic N; Bumbasirevic V; Colovic M; Pavlovic S
    Ann Hematol; 2007 Oct; 86(10):741-7. PubMed ID: 17579862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [FLT3 internal tandem duplication in patients with acute promyelocytic leukemia].
    Zhu YM; Liu YF; Zhang SJ; Shen ZX; Hu J
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):371-4. PubMed ID: 17939400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of bcr-1 and bcr-3 Isoforms of PML-RARA and FLT3-ITD in Patients With Acute Promyelocytic Leukemia.
    Rasekh EO; Elsayed GM; Madney Y; El Gammal MM
    Clin Lymphoma Myeloma Leuk; 2020 Mar; 20(3):156-167. PubMed ID: 32033928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia.
    Shih LY; Kuo MC; Liang DC; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Lai CL
    Cancer; 2003 Sep; 98(6):1206-16. PubMed ID: 12973844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
    Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
    Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.